Application of oligonucleotide array CGH to the simultaneous detection of a deletion in the nuclear TK2 gene and mtDNA depletion

• Published in: Molecular genetics and metabolism 2010, Vol.99 (1), p.53-57
• Main Authors: Zhang, Shulin, Li, Fang-yuan, Bass, Harold N., Pursley, Amber, Schmitt, Eric S., Brown, Blaire L., Brundage, Ellen K., Mardach, Rebecca, Wong, Lee-Jun
• Format: Article
• Language: English
• Subjects: Array CGH; Base Sequence; Comparative Genomic Hybridization - methods; DNA Mutational Analysis; DNA, Mitochondrial - genetics; Family Health; Fatal Outcome; Female; Humans; Male; Mitochondrial Myopathies - genetics; Mitochondrial Myopathies - pathology; mtDNA depletion; Pedigree; Point Mutation; Sequence Deletion; Thymidine Kinase - genetics; TK2 deletion
• ISSN: 1096-7192; 1096-7206
• DOI: 10.1016/j.ymgme.2009.09.003

Thymidine kinase 2 (TK2), encoded by the TK2 gene on chromosome 16q22, is one of the deoxyribonucleoside kinases responsible for the maintenance of mitochondrial deoxyribonucleotide pools. Defects in TK2 mainly cause a myopathic form of the mitochondrial DNA depletion syndrome (MDDS). Currently, only point mutations and small insertions and deletions have been reported in TK2 gene; gross rearrangements of TK2 gene and possible hepatic involvement in patients with TK2 mutations have not been described. We report a non-consanguineous Jordanian family with three deceased siblings due to mtDNA depletion. Sequence analysis of the father detected a heterozygous c.761T > A (p.I254N) mutation in his TK2 gene; however, point mutations in the mother were not detected. Subsequent gene dosage analysis using oligonucleotide array CGH identified an intragenic approximately 5.8-kb deletion encompassing the 5′UTR to intron 2 of her TK2 gene. Sequence analysis confirmed that the deletion spans c.1–495 to c.283–2899 of the TK2 gene (nucleotide 65,136,256–65,142,086 of chromosome 16). Analysis of liver and muscle specimens from one of the deceased infants in this family revealed compound heterozygosity for the paternal point mutation and maternal intragenic deletion. In addition, a significant reduction of the mtDNA content in liver and muscle was detected (10% and 20% of age- and tissue-matched controls, respectively). Prenatal diagnosis was performed in the third pregnancy. The fetus was found to carry both the point mutation and the deletion. This child died 6 months after birth due to myopathy. A serum specimen demonstrated elevated liver transaminases in two of the infants from whom results were available. This report expands the mutation spectrum associated with TK2 deficiency. While the myopathic form of MDDS appears to be the main phenotype of TK2 mutations, liver dysfunction may also be a part of the mitochondrial depletion syndrome caused by TK2 gene defects.